Antiplatelet Agents
Sponsors
Johns Hopkins University, Alfa Wassermann Tunisia, Assiut University, Centre hospitalier de l'Université de Montréal (CHUM), Beijing Tiantan Hospital
Conditions
Acute Ischemic StrokeAtheroscleroses, CoronaryAtherosclerosisCardiovascular DiseasesCarotid Artery DiseasesCarotid StenosisCerebral ArteriosclerosisCoronary Artery Disease
Phase 3
Phase 4
Unknown Phase
Coronary Artery Ectasia in Elective Coronary Angiography : Predictors, Outcomes and Management
CompletedNCT03896321
Start: 2019-12-01End: 2022-02-01Updated: 2024-02-13
Endovascular Acute Stroke Intervention - Tandem OCclusion Trial
RecruitingNCT04261478
Start: 2020-08-31End: 2027-03-31Target: 458Updated: 2023-11-18
Early-Start Antiplatelet Treatment After Neurosurgery in Patients With Spontaneous Intracerebral Hemorrhage
CompletedNCT04820972
Start: 2021-05-01End: 2023-05-01Updated: 2025-04-03
Effectiveness and Safety of Different Antithrombotic Therapy for the Treatment of Ventricular Thrombus
NCT05006677
Start: 2021-08-04End: 2023-12-30Target: 480Updated: 2023-03-02
Long Term Follow-up of Comparison of Clopidogrel vs. Aspirin Monotherapy After Drug-eluting Stent Implantation
Active, not recruitingNCT05567536
Start: 2014-03-01End: 2028-12-31Updated: 2022-10-05
A Prospective muLticEnter Registry in chrONic coronARy synDrOme
Not yet recruitingNCT06198673
Start: 2024-01-01End: 2026-12-31Target: 1000Updated: 2024-01-10
Nationwide Cohort Study of Antiplatelet Agents as Primary Prevention
CompletedNCT06281041
Start: 2013-01-01End: 2024-12-31Updated: 2025-03-14